Bobby Daly, MD, MBA, Memorial Sloan Kettering Cancer Center, breaks down prevalent touch points in oncology clinical pathways, including conflicts of interest on pathway development panels, potential for cost variation due to site of care, and interoperability challenges between vendor pathways and individual EMRs.

Vincent DeVita, MD, professor of medicine at Yale Cancer Center and former president of ACS, debates with Chadi some of the ideas laid out in his book, "The Death of Cancer," most notably the utility of randomized controlled trials in regulatory approvals.

Vincent DeVita, MD, professor of medicine at Yale Cancer Center and former president of ACS, debates with Chadi some of the ideas laid out in his book, "The Death of Cancer," most notably the utility of randomized controlled trials in regulatory approvals.

Mark A Lewis, MD, director of GI oncology, Intermountain Healthcare, spoke with Chadi to classify the AYA patient population, explain the disconnect of clinical trial accrual in this population, and pose social media as a critical avenue for overcoming this barrier.

Mark A Lewis, MD, director of GI oncology, Intermountain Healthcare, spoke with Chadi to classify the AYA patient population, explain the disconnect of clinical trial accrual in this population, and pose social media as a critical avenue for overcoming this barrier.

Pat Basu, MD, MBA, president and CEO of Cancer Treatment Centers of America and former Senior Advisor to President Obama in the White House, shares with Chadi his unique experience of combining the clinical health care discipline with business and policy to help patients on a population level.

Pat Basu, MD, MBA, president and CEO of Cancer Treatment Centers of America and former Senior Advisor to President Obama in the White House, shares with Chadi his unique experience of combining the clinical health care discipline with business and policy to help patients on a population level.

Sekar Kathiresan, MD, sits down with Chadi to discuss his unique career path from esteemed cardiologist and physician-geneticist at Massachusetts General Hospital to co-founder and CEO of Verve Therapeutics.

Sekar Kathiresan, MD, sits down with Chadi to discuss his unique career path from esteemed cardiologist and physician-geneticist at Massachusetts General Hospital to co-founder and CEO of Verve Therapeutics.

Opinions collide in this spirited debate about how physicians can and should enter conversations on political issues as Chadi and returning guest Saurabh Jha expound on a recent Lancet article focused on the Kashmir conflict.